European Journal of Surgical Oncology
Volume 34, Issue 6 , Pages 642-647 , June 2008

Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients

  • S. Gretschel

      Affiliations

    • Charité, Universitätsmedizin Berlin, Campus Buch, Klinik für Chirurgie und Chirurgische Onkologie, Robert-Rössle-Klinik, Helios Klinikum, Berlin, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 30 94171400; fax: +49 30 94171404.
    • ,
  • Ch. Astrosini

      Affiliations

    • Centrum für Anatomie, Institut für Integrative Neuroanatomie, Charité, Campus Mitte, Berlin, Germany
    • ,
  • M. Vieth

      Affiliations

    • Institut für Pathologie, Klinikum Bayreuth, Bayreuth, Germany
    • ,
  • Th. Jöns

      Affiliations

    • Centrum für Anatomie, Institut für Integrative Neuroanatomie, Charité, Campus Mitte, Berlin, Germany
    • ,
  • T. Tomov

      Affiliations

    • Charité, Universitätsmedizin Berlin, Campus Buch, Klinik für Chirurgie und Chirurgische Onkologie, Robert-Rössle-Klinik, Helios Klinikum, Berlin, Germany
    • ,
  • M. Höcker

      Affiliations

    • Centrum für Anatomie, Institut für Integrative Neuroanatomie, Charité, Campus Mitte, Berlin, Germany
    • ,
  • P.M. Schlag

      Affiliations

    • Charité, Universitätsmedizin Berlin, Campus Buch, Klinik für Chirurgie und Chirurgische Onkologie, Robert-Rössle-Klinik, Helios Klinikum, Berlin, Germany
    • ,
  • W. Kemmner

      Affiliations

    • Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany

,Accepted 14 September 2007.

References 

  1. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995;333(26):1757–1763
  2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70
  3. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407(6801):242–248
  4. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst. 1990;82(1):4–6
  5. Folkman J. Tumour angiogenesis and tissue factor. Nat Med. 1996;2(2):167–168
  6. Liotta LA. Cancer cell invasion and metastasis. Sci Am. 1992;266(2):59–62
  7. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240(5):808–816
  8. Tajima Y, Yamazaki K, Nishino N, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery – immunohistochemical analysis of 213 lesions. Br J Cancer. 2004;91(7):1342–1348
  9. Fukagawa T, Sasako M, Mann GB, et al. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer. 2001;92(4):753–760
  10. Schlimok G, Funke I, Pantel K, et al. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer. 1991;27(11):1461–1465
  11. Heiss MM, Allgayer H, Gruetzner KU, Babic R, Jauch KW, Schildberg FW. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer. Ann Surg. 1997;226(6):736–744
  12. Macadam R, Sarela A, Wilson J, MacLennan K, Guillou P. Bone marrow micrometastases predict early post-operative recurrence following surgical resection of oesophageal and gastric carcinoma. Eur J Surg Oncol. 2003;29(5):450–454
  13. Gretschel S, Schick C, Schneider U, Estevez-Schwarz L, Bembenek A, Schlag PM. Prognostic value of cytokeratin-positive bone marrow cells of gastric cancer patients. Ann Surg Oncol. 2007;14(2):373–380
  14. Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer. 2001;37(7):918–923
  15. Juttner S, Wissmann C, Jons T, et al. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol. 2006;24(2):228–240
  16. Maehara Y, Hasuda S, Abe T, et al. Tumour angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer. Clin Cancer Res. 1998;4(9):2129–2134
  17. Spence GM, Graham AN, Mulholland K, et al. Bone marrow micrometastases and markers of angiogenesis in esophageal cancer. Ann Thorac Surg. 2004;78(6):1944–1949
  18. Kakeji Y, Maehara Y, Shibahara K, et al. Clinical significance of micrometastasis in bone marrow of patients with gastric cancer and its relation to angiogenesis. Gastric Cancer. 1999;2:46–51
  19. Matsunami K, Nakamura T, Oguma H, Kitamura Y, Takasaki K. Detection of bone marrow micrometastasis in gastric cancer patients by immunomagnetic separation. Ann Surg Oncol. 2003;10(2):171–175
  20. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue, Pathologie. 1987;8(3):138–140
  21. Fox SB, Leek RD, Bliss J, et al. Association of tumour angiogenesis with bone marrow micrometastases in breast cancer patients. J Natl Cancer Inst. 1997;89(14):1044–1049
  22. Nakamura T, Matsunami K, Hayashi K, Ota M, Ide H, Takasaki K. Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation. Oncol Rep. 2004;11(5):999–1003
  23. Nagy JA, Vasile E, Feng D, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med. 2002;196(11):1497–1506
  24. Hong YK, Lange-Asschenfeldt B, Velasco P, et al. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J. 2004;18(10):1111–1113
  25. Maehara Y, Kabashima A, Koga T, et al. Vascular invasion and potential for tumour angiogenesis and metastasis in gastric carcinoma. Surgery. 2000;128(3):408–416
  26. Takahashi Y, Cleary KR, Mai M, et al. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res. 1996;2(10):1679–1684
  27. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumour cells via the lymphatics. Nat Med. 2001;7(2):186–191
  28. Ishikawa M, Kitayama J, Kazama S, Nagawa H. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol. 2003;33(1):21–27
  29. Ichikura T, Tomimatsu S, Ohkura E, et al. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol. 2001;78(2):132–137
  30. Yonemura Y, Endo Y, Fujita H, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res. 1999;5(7):1823–1829
  31. Amioka T, Kitadai Y, Tanaka S, et al. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer. 2002;38(10):1413–1419
  32. Takahashi H, Kondo T. Development of antiangiogenic chemotherapy regimens, Nippon Geka Gakkai Zasshi. 2002;103(2):237–243
  33. Karpanen T, Egeblad M, Karkkainen MJ, et al. Vascular endothelial growth factor C promotes tumour lymphangiogenesis and intralymphatic tumour growth. Cancer Res. 2001;61(5):1786–1790

PII: S0748-7983(07)00541-0

doi: 10.1016/j.ejso.2007.09.010

European Journal of Surgical Oncology
Volume 34, Issue 6 , Pages 642-647 , June 2008

Article Tools

* Image Usage & Resolution